FY2025 · ended Dec 31, 2025 · Revenue $537,080, -39.9% YoY · Filed Mar 31, 2026
Quantum Cyber N.V. (QUCY) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $537,080 and a net loss of $16.2 million. Free cash flow was -$11.0 million.
Revenue
$537,080
-39.9% vs prior year
Net income
$-16.21M
Operating cash flow
$-10.98M
+35.8% vs prior year
Free cash flow
$-10.98M
+36.1% vs prior year
EPS
$-2.70
Dividend per share
None
Shares outstanding
12.52M
+439.6% vs prior year
Net cash
$-1.42M
FY 2025
Operating margin
-3005.0%
FY 2025
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QUCY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Mainz
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1874252
- Former names
- MAINZ BIOMED N.V. (until Apr 15, 2026); Mainz Biomed B.V. (until Nov 12, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $537,080 | $893,991 | $895,479 | $529,877 | $577,348 |
| Operating income | -$16.1M | — | — | — | — |
| Net income | -$16.2M | — | — | — | — |
| Diluted EPS | -$2.70 | — | — | — | — |
| Operating cash flow | -$11.0M | -$17.1M | -$21.9M | -$14.8M | -$3.2M |
| Free cash flow | -$11.0M | -$17.2M | -$23.1M | -$15.4M | -$3.2M |
| Total assets | $5.3M | $13.5M | $15.4M | $20.2M | $10.0M |
| Total liabilities | $4.7M | $7.5M | $12.2M | $6.1M | $3.7M |
| Stockholders' equity | $641,600 | — | — | — | — |
| Cash and investments | $889,091 | $6.2M | $7.1M | $17.1M | $8.7M |
| Total debt | $2.3M | $1.1M | $1.5M | $1.3M | $543,891 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 9, 2026 | Oct 9, 2026 |
| 8-K/A | Amended current report | Sep 25, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 25, 2026 | Sep 25, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2026 | Jul 24, 2026 |
All 204 Quantum Cyber N.V. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.